The potent inhibition of succinate dehydrogenase by oxaloacetate involves a lag period during which the degree of inhibition gradually increases. Reversal of inhibition by excess of succinate also occurs slowly. Wojtczak et al. (1969) suggest that oxaloacetate induces a reversible conformation change in the enzyme, whereas Zeylemaker el al. (1969) propose the rapid formation of an initial El complex followed by its slow conversion into a second, tighter, EI'complex. Most recently, Vinogradov et al. (1972) have implicated an enzyme thiol group and suggest thiosemiacetal formation as the slow step. The interconversion may thus involve changes in enzyme chemistry or conformation as well as the keto-enol tautomerism of oxaloacetate. We used fluorinated inhibitor analogues to study this problem, since introduction of one fluorine atom into oxaloacetate decreases enolization (Hellerman et al., 1960; Kun et al., 1958) and enolization is precluded in the case of difluoro-oxaloacetate. The enol form of oxaloacetate is approximately isosteric with monofluoromaleate, and the effects of halo-substituted maleates were therefore also examined.
reaction mixtures, and equilibrium inhibition was obtained by incubating enzyme with inhibitor and succinate before starting the reaction with phenazine methosulphate. Traces of oxaloacetate were determined fluorimetrically, with malate dehydrogenase and NADH.
As reported (Wojtczak et al., 1969; Zeylemaker et al., 1969) , oxaloacetate inhibition increased with time. The final inhibition was competitive, and K, (oxaloacetate) was between 0.1 and 0 . 2~~ and K,,, (succinate) was 0.2-0.5m~. Monofluoro-oxaloacetate and difluoro-oxaloacetate showed a similar slow inhibitory effect, as did fluorofumarate and fluoromaleate. Fumarate, maleate, chloromaleate and bromomaleate gave an immediate inhibition that did not increase with time (as with the classical inhibitor malonate). Addition of excess of succinate reversed the inhibition in all cases. A marked lag was again observed with the oxaloacetates. Inhibition constants calculated from double-reciprocal plots are listed in Table 1 . Monofluoro-oxaloacetate has a much larger Kt than oxaloacetate. This confirms the report by Hellerman et al. (1960) , and suggests that oxaloacetate inhibition may involve the en01 form, diminished in concentration on the substitution of hydrogen by fluorine. Difluoro-oxaloacetate is a still weaker inhibitor. Difference spectra of the enzyme in the presence and in the absence of these inhibitors have shown that all three give complexes of the oxaloacetate type, whereas all the 'fast' inhibitors give complexes of the malonate type (Tober et a/., 1970).
Fluorofumarate and fluoromaleate also behave as 'slow' inhibitors, but inhibition is attributable to other factors. Oxaloacetate can be produced from fluorofumarate by traces of fumarase in the dehydrogenase preparation (Tober et al., 1970) . Fluoromaleate as prepared also forms oxaloacetate; and 0.01 "/, oxaloacetate induces an appreciable where k is the first-order rate (Fig. 1) . koii: calculated from the rate of reactivation by succinate according to: koff = l/'lag' time.
4: obtained by direct equilibration in the presence of inhibitor and succinate (competitive). Conditions were as described in the legend to Fig. 1 * At inhibitor concentrations giving 50-90% inhibition. t Type I spectrum: like that induced by malonate (peak at 510nm in difference spectrum); type I1 spectrum: like that induced by oxaloacetate (broad absorption in the range 530-600nm in difference spectrum).
$ When the contribution due to contaminant oxaloacetate is eliminated (see the text).
inhibition. But, if final traces of oxaloacetate are removed by heating at pH7.8 (100°C for 5 min), the resulting fluoromaleate gives a high Ki (approx. 2 . 7 r n~) and shows no inhibition increase with time. A time-course of inhibition by oxaloacetate is shown in Fig. 1 . If such exponential curves, representing inhibitor binding, are replotted in semi-logarithmic form, straight lines are then obtained, as in Fig. l(b) . Similar results were obtained with the two fluoro analogues. , 1970) . Indeed, it approaches the rate of succinate binding (Tober etal., 1970) . The rate of release of inhibition (approx. 0.005s-') is similar to that observed by Wojtczak et al. (1969) . If the enol form of oxaloacetate were the initially reactive form, the marked decrease in reactivity of the monofluoro-and difluoro-substituted analogues would be expected. However, the slow dissociation cannot be attributed to keto-enol interconversion, as it also characterizes the release of difluoro-oxaloacetate inhibition. The latter compound cannot exist in the enol form. We believe that a preferred initial reaction of the enzyme with the enol form of oxaloacetate is followed by either an intramolecular protein conformation change or by the thiosemiacetal reaction proposed by Vinogradov et al. (1972) . Differences in the reactivity of the soluble and membranebound enzymes may be associated with different enzyme conformations or thiol accessibilities in the two environments. Like Wojtczak et al. (1969 to separate the two postulated steps (Zeyleniaker et al., 1969) in the reaction (Fig. 1) . Whether or not the rate constants are such as to permit such a separation may be a fairly subtle function of the preparation of enzyme employed. The early stages of the response to a severe injury in the post-absorptive rat in a 20°C environment are characterized by a fall in body temperature, with lower rates of whole-body O2 consumption and of glucose and free fatty acid oxidation (Stoner, 1970) . After one such injury, bilateral hind-limb ischaemia, the concentration of ketone bodies in the liver rose, apparently because a higher proportion of the free fatty acids utilized were converted into them (Barton, 1971) . This raised the question whether there was a corresponding increase in the rates of utilization of ketone bodies by extrahepatic tissues. The rates of utilization can be written in the form k . V . C, where Cis the blood concentration and k . V is a proportionality constant. Experiments i n control rats with Bhydr~xy['~C]butyrate and [14C]acetoacetate showed that for both substrates k . V was independent of concentration, so that the rate of utilization was proportional to concentration, and values of k . V could be calculated (Barton, 1972) . For acetoacetate k . V (20.9k0.7, s.E.M., ml .rnin-'. 1OOg-') was much higher than for 13-hydroxybutyrate (5.8 +0.3 ml . m i -' . 1OOg-I). Multiplied by their respective concentrations these values gave a total rate of utilization of ketone bodies of 2.5 (1.6-3.9, S.D. range) pmol .min-'. 1OOg-' ; the large standard deviation is due to the variability of the concentrations. The mean rate is equivalent to about 7 % of the whole-body O2 consumption at 20°C (Stoner, 1969) , assuming complete oxidation. After hind-limb ischaemia, the rates of utilization of B-hydroxybutyrate and acetoacetate were still proportional to their blood concentrations, and the values of k . V were respectively 12.1 *0.4 and 4.0~0.2ml-min-'-100g-1. Since k . V is a complex coefficient, these values should not be directly compared with those in the controls.
Owing to an increase in the mean concentrations of both B-hydroxybutyrate and acetoacetate, their total rate of utilization rose to 3.4 (2.3-5.1, S.D. range) pmol.min-*. 1OOg-', in contrast with the decreased rates of glucose and free fattyacid oxidation. This is equivalent to an average of 15 % of the O2 consumption, which falls by 44% in these rats (Stoner, 1969) .
These results emphasize that at these relatively low concentrations utilization of ketone bodies is a passive process and that its rate is determined by concentration. 
